These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
842 related items for PubMed ID: 2488233
1. The p53 tumor suppressor gene and gene product. Levine AJ. Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233 [Abstract] [Full Text] [Related]
2. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B, Levine AJ. Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874 [Abstract] [Full Text] [Related]
3. The properties of p53 proteins selected for the loss of suppression of transformation. Olson DC, Levine AJ. Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594 [Abstract] [Full Text] [Related]
7. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells. Su ZZ, Leon JA, Jiang H, Austin VN, Zimmer SG, Fisher PB. Cancer Res; 1993 Apr 15; 53(8):1929-38. PubMed ID: 8385576 [Abstract] [Full Text] [Related]
18. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ, Austin VN, Zimmer SG, Fisher PB. Oncogene; 1993 May 15; 8(5):1211-9. PubMed ID: 8479744 [Abstract] [Full Text] [Related]
20. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras. Hansen RS, Braithwaite AW. Oncogene; 1996 Sep 05; 13(5):995-1007. PubMed ID: 8806689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]